Despite all IDH-mutant gliomas seeming to originate from a shared progenitor [7,28], oligodendrogliomas and astrocytomas differ according to morphological aspects, genetic mutations, and TME composition, with subsequent differences in tumor behavior and clinical outcomes. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).